Failure to increase postprandial blood flow in subcutaneous adipose tissue is associated with tissue resistance to adrenergic stimulation

Diabetes and Metabolism

Volumn 38, Issue 1, 2012, Pages 27-33

  Ardilouze, J L ^a,b   Sotornik R ^a   Dennis, L A ^c   Fielding, B A ^c   Frayn, K N ^c   Karpe, F ^c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adipose tissue; Blood flow; Insulin resistance; MONW; Sympathetic nervous system

Indexed keywords

GLUCOSE; ISOPRENALINE; XENON 133;

ADIPOSE TISSUE BLOOD FLOW; ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; BODY MASS; COHORT ANALYSIS; FEMALE; HUMAN; MALE; NORMAL HUMAN; SKINFOLD THICKNESS; SUBCUTANEOUS FAT;

ADRENERGIC AGONISTS; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DRUG RESISTANCE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; POSTPRANDIAL PERIOD; QUESTIONNAIRES; REGIONAL BLOOD FLOW; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; SYMPATHETIC NERVOUS SYSTEM;

EID: 84856714966     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.06.005     Document Type: Article

References (34)

1. Summers L.K., Samra J.S., Humphreys S.M., Morris R.J., Frayn K.N. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci (Lond) 1996, 91:679-683.
2. Karpe F., Fielding B.A., Ilic V., Macdonald I.A., Summers L.K., Frayn K.N. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002, 51:2467-2473.
3. Laaksonen D.E., Nuutinen J., Lahtinen T., Rissanen A., Niskanen L.K. Changes in abdominal subcutaneous fat water content with rapid weight loss and long-term weight maintenance in abdominally obese men and women. Int J Obes Relat Metab Disord 2003, 27:677-683.
4. Dimitriadis G., Lambadiari V., Mitrou P., Maratou E., Boutati E., Panagiotakos D.B., et al. Impaired postprandial blood flow in adipose tissue may be an early marker of insulin resistance in type 2 diabetes. Diabetes Care 2007, 30:3128-3130.
5. Karpe F., Fielding B.A., Ardilouze J.L., Ilic V., Macdonald I.A., Frayn K.N. Effects of insulin on adipose tissue blood flow in man. J Physiol 2002, 540:1087-1093.
6. Ardilouze J.L., Fielding B.A., Currie J.M., Frayn K.N., Karpe F. Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 2004, 109:47-52.
7. Barbe P., Millet L., Galitzky J., Lafontan M., Berlan M. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996, 117:907-913.
8. Blaak E.E., van Baak M.A., Kemerink G.J., Pakbiers M.T., Heidendal G.A., Saris W.H. Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism 1995, 44:183-187.
9. Blaak E.E., Kemerink G.J., Pakbiers M.T., Wolffenbuttel B.H., Heidendal G.A., Saris W.H. Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes. Clin Sci (Lond) 1999, 97:421-428.
10. Ardilouze J.L., Karpe F., Currie J.M., Frayn K.N., Fielding B.A. Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall. Int J Obes Relat Metab Disord 2004, 28:228-233.
11. Durnin J.V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974, 32:77-97.
12. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
13. Pereira M.A., FitzerGerald S.J., Gregg E.W., Joswiak M.L., Ryan W.J., Suminski R.R., et al. A collection of Physical Activity Questionnaires for health-related research. Med Sci Sports Exerc 1997, 29:S1-S205.
14. Clark M.L., Humphreys S.M., Frayn K.N. Stability of plasma glucose during storage. Ann Clin Biochem 1990, 27(Part 4):373-377.
15. Belfiore F., Iannello S., Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998, 63:134-141.
16. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192.
17. Jordan J., Tank J., Stoffels M., Franke G., Christensen N.J., Luft F.C., et al. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 2001, 86:2803-2810.
18. Diggs-Andrews K.A., Zhang X., Song Z., Daphna-Iken D., Routh V.H., Fisher S.J. Brain insulin action regulates hypothalamic glucose sensing and the counter regulatory response to hypoglycaemia. Diabetes 2010, 59:2271-2280.
19. Berne C., Fagius J., Pollare T., Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992, 35:873-879.
20. O'Dea K., Esler M., Leonard P., Stockigt J.R., Nestel P. Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 1982, 31:896-899.
21. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992, 13:387-414.
22. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001, 19:523-528.
23. Baskin D.G., Figlewicz D.P., Woods S.C., Porte D., Dorsa D.M. Insulin in the brain. Annu Rev Physiol 1987, 49:335-347.
24. Esler M., Jennings G., Lambert G., Meredith I., Horne M., Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990, 70:963-985.
25. Vaz M., Jennings G., Turner A., Cox H., Lambert G., Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96:3423-3429.
26. Snapir A., Koskenvuo J., Toikka J., Orho-Melander M., Hinkka S., Saraste M., et al. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci (Lond) 2003, 104:509-520.
27. Dishy V., Sofowora G.G., Xie H.G., Kim R.B., Byrne D.W., Stein C.M., et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001, 345:1030-1035.
28. Sivenius K., Niskanen L., Laakso M., Uusitupa M. A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity. Obes Res 2003, 11:962-970.
29. Ruderman N.B., Schneider S.H., Berchtold P. The "metabolically-obese", normal-weight individual. Am J Clin Nutr 1981, 34:1617-1621.
30. Stallknecht B., Lorentsen J., Enevoldsen L.H., Bülow J., Biering-Sørensen F., Galbo H., et al. Role of the sympathoadrenergic system in adipose tissue metabolism during exercise in humans. J Physiol 2001, 536:283-294.
31. Conus F., Rabasa-Lhoret R., Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007, 32:4-12.
32. Boschmann M., Schroeder C., Christensen N.J., Tank J., Krupp G., Biaggioni I., et al. Norepinephrine transporter function and autonomic control of metabolism. J Clin Endocrinol Metab 2002, 87:5130-5137.
33. Broadley K.J. Review of mechanisms involved in the apparent differential desensitization of beta1- and beta2-adrenoceptor-mediated functional responses. J Auton Pharmacol 1999, 19:335-345.
34. Dhalla A.K., Shryock J.C., Shreeniwas R., Belardinelli L. Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 2003, 3:369-385.